查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2085741

心臟瓣膜器械市場：2026-2032年全球市場預測（按瓣膜位置、產品類型、手術方式、年齡層、最終用戶和分銷管道分類）

Heart Valve Devices Market by Valve Position, Product Type, Procedure Type, Age Group, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，心臟瓣膜裝置市場將成長至 268.9 億美元，複合年成長率為 10.39%。

主要市場統計數據
基準年 2025 134.5億美元
預計年份：2026年 148.2億美元
預測年份 2032 268.9億美元
複合年成長率 (%) 10.39%

心臟瓣膜裝置在治療主動脈瓣、二尖瓣、三尖瓣和肺動脈瓣疾病中發揮核心作用，包括機械瓣膜、生物瓣膜、瓣環成形術系統、經導管主動脈瓣置換術術 (TAVR) 平台、經導管二尖瓣瓣膜修復和置換技術以及新的三尖瓣療法。

需求主要受人口統計和臨床因素驅動，包括人口老化、老年人群中鈣化性主動脈瓣狹窄的高發生率、許多中低收入國家持續存在的風濕性心臟疾病負擔，以及微創結構性心臟疾病治療手段的日益普及。隨著基於價值的報銷模式的擴展，醫院、心臟中心和門診心血管計畫正優先部署能夠提高存活率、縮短復健時間和維持治療效果的瓣膜裝置。

心臟瓣膜裝置領域的變革性變化

心臟瓣膜器械的格局正在轉變，從開胸手術進行瓣膜置換轉向基於導管或混合式結構性心臟介入治療。經導管主動脈瓣置換術術（TAVR）在隨機臨床試驗證據和臨床指引的支持下，正不斷擴大其在關鍵市場的覆蓋範圍，從不合格手術或高風險的患者擴展到更廣泛的風險類別。這加速了對輸送系統、影像相容性、瓣膜耐久性和治療計劃流程的投資。

人工智慧（AI）的累積影響

人工智慧 (AI) 正開始影響心臟瓣膜裝置的整個生命週期，從診斷和患者選擇到手術計劃和上市後監測。 AI 驅動的心臟超音波圖、CT 分割和自動化測量工具可以幫助更準確地評估瓣環尺寸、鈣化程度、左心室功能和手術風險。

關鍵區域洞察

亞太地區蘊藏著巨大的機遇，中國、印度、日本、韓國和澳洲都在積極拓展其結構性心臟疾病計畫。此外，龐大的老齡人口和日益完善的三級心臟醫療服務也推動了對外科手術和經導管心臟瓣膜裝置的需求。日本和澳洲受益於成熟的保險報銷系統和先進的醫院基礎設施。與此同時，中國和印度憑藉其龐大的患者群體、不斷提升的國內製造能力、更便捷的診斷服務以及公私合作對心臟醫療保健的大力投資，正經歷著市場擴張。

關鍵群體特定見解

在東協地區，都市區醫院網路的擴張和人們對心血管疾病認知的提高正逐步推動心臟瓣膜裝置的應用，尤其是在新加坡、泰國、馬來西亞、印尼、越南和菲律賓。然而，該地區醫療資源的可及性仍然不均衡，因此，完善醫保報銷體系、加強醫生培訓、轉診途徑以及發展核心區域醫療中心，對於擴大外科瓣膜、經導管主動脈瓣置換術（TAVR）以及新型二尖瓣和三尖瓣治療方法的應用至關重要。

主要國家的概況

美國是全球最大的心臟瓣膜器械商業和臨床創新市場，這得益於FDA批准的技術、大規模的註冊登記系統、TAVR的高普及率以及廣泛的結構性心臟疾病計畫。在加拿大，實證醫學的應用正透過省級醫療保健系統逐步推進；而在墨西哥，私立醫院和主要城市心臟中心正在擴大醫療服務的覆蓋範圍。巴西是拉丁美洲的主要市場，其需求受到公私合營醫療模式、先進的循環系統中心以及持續應對退化性瓣膜疾病和風濕性瓣膜疾病需求的驅動。

為行業領導者提供的實用建議

產業領導者應優先考慮差異化的臨床證據，包括長期耐久性、生活品質 (QOL) 結果、降低再入院率、中風和心律調節器相關結局，以及器械在解剖結構複雜患者中的表現。證據策略應包括隨機試驗、真實世界註冊研究、衛生經濟學分析，以及符合植入式心血管器材監管要求的上市後監測（如可行）。

調查方法

本執行摘要基於系統性的二次研究，包括同行評審的循環系統文獻、主要學術指南、公共監管文件、臨床試驗註冊、醫院採用趨勢以及心臟瓣膜疾病和心血管醫學的流行病學數據。

結論

隨著人口老化、瓣膜性心臟病診斷不足以及臨床上對微創介入治療的偏好，心血管治療格局正在改變，心臟瓣膜裝置預計將繼續發展。儘管經導管主動脈瓣置換術（TAVR）仍然是變革的標桿，但二尖瓣和三尖瓣領域的創新正在為結構性心臟疾病治療的下一階段鋪平道路。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 心臟瓣膜器械市場：依瓣膜位置分類

  • 主動脈瓣
  • 二尖瓣
  • 肺動脈瓣
  • 三尖瓣

第8章 心臟瓣膜裝置市場：依產品類型分類

  • 機械心臟瓣膜
    • 二尖瓣
    • 傾斜盤
    • 帶籠球
  • 生物心臟瓣膜
    • 異質骨移植
    • 同種異體移植

第9章：心臟瓣膜裝置市場：依手術類型分類

  • 經導管瓣膜治療
  • 開胸手術
  • 微創手術

第10章：心臟瓣膜裝置市場：依年齡層別分類

  • 成人
  • 兒童
  • 老年人

第11章 心臟瓣膜裝置市場：依最終使用者分類

  • 門診手術中心
  • 醫院
  • 循環系統專科診所
  • 研究和學術機構

第12章 心臟瓣膜器械市場：依通路分類

  • 線上
  • 離線

第13章 心臟瓣膜裝置市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章 心臟瓣膜器械市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 心臟瓣膜器械市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Edwards Lifesciences Corporation
  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Corcym Srl
  • Artivion, Inc
  • Peijia Medical Limited
  • Meril Life Sciences Pvt. Ltd.
  • Venus Medtech（Hangzhou）Inc.
  • Lepu（Beijing）Medical Devices Co., Ltd.
  • Biosensors International Group, Ltd.
  • MicroPort Scientific Corporation
  • JenaValve Technology, Inc.
  • 4C Medical Technologies, Inc.
  • Anteris Technologies Global Corp.
  • Braile Biomedica
  • Colibri Heart Valve LLC
  • Foldax, Inc.
  • HighLife Medical
  • Sahajanand Medical Technologies Limited
  • TTK Healthcare Limited
  • WL Gore & Associates, Inc.
  • Xeltis BV
Product Code: MRR-437E9896A569

The Heart Valve Devices Market is projected to grow by USD 26.89 billion at a CAGR of 10.39% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 13.45 billion
Estimated Year [2026] USD 14.82 billion
Forecast Year [2032] USD 26.89 billion
CAGR (%) 10.39%

Heart valve devices are central to the treatment of aortic, mitral, tricuspid, and pulmonary valve disease, spanning mechanical valves, bioprosthetic valves, annuloplasty systems, transcatheter aortic valve replacement (TAVR) platforms, transcatheter mitral repair and replacement technologies, and emerging tricuspid solutions.

Demand is supported by well-documented demographic and clinical drivers: population aging, the high prevalence of calcific aortic stenosis in older adults, persistent rheumatic heart disease burden in many low- and middle-income countries, and growing use of minimally invasive structural heart procedures. Hospitals, cardiac centers, and ambulatory cardiovascular programs are prioritizing heart valve devices that improve survival, reduce recovery time, and support durable outcomes under increasingly value-based reimbursement models.

Transformative Shifts in the Heart Valve Devices Landscape

The heart valve devices landscape is shifting from open surgical valve replacement toward catheter-based and hybrid structural heart interventions. TAVR has moved from inoperable and high-risk patients into broader risk categories in major markets, supported by randomized clinical evidence and guideline adoption. This has accelerated investment in delivery systems, imaging compatibility, valve durability, and treatment planning workflows.

Another transformative shift is the expansion beyond aortic valve disease. Mitral and tricuspid valve therapies are gaining clinical and commercial attention because these conditions are common in older and heart failure populations, yet historically undertreated. Device development is increasingly focused on precision delivery, reduced paravalvular leak, lower pacemaker rates, retrievability, and long-term hemodynamic performance.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to influence the full heart valve device lifecycle, from diagnosis and patient selection to procedural planning and post-market surveillance. AI-enabled echocardiography, CT segmentation, and automated measurement tools can support more consistent assessment of annular dimensions, calcification, left ventricular function, and procedural risk.

The cumulative impact is operational as well as clinical. AI can improve cath lab scheduling, inventory planning, and real-world evidence generation by analyzing registry data, imaging archives, and electronic health records. However, adoption depends on validated algorithms, transparent regulatory pathways, cybersecurity controls, and clinician oversight to ensure that AI augments, rather than replaces, expert structural heart decision-making.

Key Regional Insights

Asia-Pacific is a high-opportunity region as China, India, Japan, South Korea, and Australia expand structural heart programs, while large elderly populations and improving access to tertiary cardiac care increase demand for both surgical and transcatheter heart valve devices. Japan and Australia benefit from mature reimbursement systems and advanced hospital infrastructure, while China and India combine large patient pools with rising domestic manufacturing capabilities, improving diagnostic access, and public-private investment in cardiac care.

North America remains a leading innovation and adoption hub due to high structural heart procedure volumes, sophisticated imaging infrastructure, strong clinical trial activity, and established reimbursement for approved TAVR and selected transcatheter valve procedures. Europe shows broad clinical expertise and guideline-driven adoption, with the European Union emphasizing medical device regulation, evidence generation, unique device identification, and post-market performance monitoring for cardiovascular implants.

Latin America, the Middle East, and Africa present mixed but important adoption conditions. Brazil and Mexico anchor Latin American demand through large urban cardiology networks and public-private treatment pathways, while GCC countries in the Middle East invest in specialist cardiac centers, advanced imaging, and medical tourism. In Africa, rheumatic heart disease continues to drive valve disease burden, particularly among younger populations, but access is constrained by specialist availability, affordability, uneven surgical capacity, and limited structural heart infrastructure.

Key Group Insights

Within ASEAN, expanding urban hospital networks and rising cardiovascular disease awareness are supporting gradual uptake of heart valve devices, especially in Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines. Access remains uneven across the region, making reimbursement design, physician training, referral pathways, and regional centers of excellence critical for wider adoption of surgical valves, TAVR, and emerging mitral and tricuspid interventions.

The GCC is characterized by high healthcare investment, growing structural heart capabilities, and demand for premium minimally invasive cardiovascular technologies. The European Union is shaped by rigorous clinical evidence expectations under the Medical Device Regulation, while BRICS countries combine large unmet need with cost-sensitive procurement, expanding tertiary hospital capacity, and growing domestic production capacity for cardiovascular devices.

G7 markets lead in innovation, clinical trial density, advanced imaging, registry participation, and early adoption of next-generation transcatheter valve devices. NATO countries overlap significantly with high-income cardiovascular markets, where procurement resilience, supply chain security, cybersecurity readiness, and clinical standardization are increasingly important to hospital systems, payers, and device manufacturers.

Key Country Insights

The United States is the largest commercial and clinical innovation market for heart valve devices, supported by FDA-authorized technologies, large registry infrastructure, high TAVR penetration, and extensive structural heart programs. Canada follows evidence-based adoption through provincial health systems, while Mexico is expanding access through private hospitals and major urban cardiac centers. Brazil is Latin America's key market, with demand shaped by public-private care pathways, advanced cardiology hubs, and the continued need to address both degenerative and rheumatic valve disease.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain strong procedure capabilities and established cardiothoracic and interventional cardiology expertise, with Germany historically recognized for high structural heart procedure volumes. Russia has demand from aging populations and cardiovascular disease burden, although access to advanced technologies can be affected by procurement complexity, reimbursement variation, and geopolitical constraints.

China and India represent large long-term opportunities due to population scale, aging demographics, rising diagnosis of valvular heart disease, and expanding cardiac infrastructure. Japan and South Korea are advanced technology markets with strong physician expertise, high-quality hospital systems, and structured adoption of minimally invasive valve procedures, while Australia combines high clinical standards, reimbursement discipline, registry-based evaluation, and systematic adoption of approved heart valve technologies.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize differentiated clinical evidence, including long-term durability, quality-of-life outcomes, reduced rehospitalization, stroke and pacemaker outcomes, and device performance in anatomically complex patients. Evidence strategies should include randomized trials where feasible, real-world registries, health-economic analyses, and post-market surveillance aligned with regulatory expectations for implantable cardiovascular devices.

Manufacturers should also invest in physician education, imaging-based planning tools, proctoring programs, and center-of-excellence partnerships to improve outcomes and accelerate appropriate adoption. Commercial strategies should balance premium innovation in mature markets with affordability, local partnerships, training infrastructure, and service support in emerging markets where diagnosis and treatment access gaps remain substantial.

Research Methodology

This executive summary is based on structured secondary research, including peer-reviewed cardiology literature, major society guidelines, public regulatory documents, clinical trial registries, hospital adoption trends, and epidemiological sources covering valvular heart disease and cardiovascular care.

The analysis applies cross-validation across clinical, regulatory, demographic, and commercial indicators. Regional, group, and country insights were assessed through healthcare infrastructure, reimbursement maturity, disease burden, procedure adoption, availability of specialist structural heart programs, regulatory readiness, and access to advanced cardiac imaging.

Conclusion

Heart valve devices are positioned for continued advancement as aging populations, underdiagnosed valve disease, and clinical preference for minimally invasive intervention reshape cardiovascular care. TAVR remains the benchmark for transformation, while mitral and tricuspid innovation is opening the next phase of structural heart development.

Organizations that combine robust clinical evidence, AI-enabled workflow support, physician training, resilient supply chains, and market-specific access strategies will be best positioned to improve adoption while strengthening patient outcomes across mature and emerging healthcare systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Heart Valve Devices Market, by Valve Position

  • 7.1. Aortic Valve
  • 7.2. Mitral Valve
  • 7.3. Pulmonary Valve
  • 7.4. Tricuspid Valve

8. Heart Valve Devices Market, by Product Type

  • 8.1. Mechanical Heart Valves
    • 8.1.1. Bileaflet
    • 8.1.2. Tilting Disc
    • 8.1.3. Caged Ball
  • 8.2. Biological Heart Valves
    • 8.2.1. Xenograft
    • 8.2.2. Homograft

9. Heart Valve Devices Market, by Procedure Type

  • 9.1. Transcatheter Valve Interventions
  • 9.2. Open-Heart Surgery
  • 9.3. Minimally Invasive Surgery

10. Heart Valve Devices Market, by Age Group

  • 10.1. Adult
  • 10.2. Pediatric
  • 10.3. Geriatric

11. Heart Valve Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Specialty Cardiology Clinics
  • 11.4. Research & Academic Centers

12. Heart Valve Devices Market, by Distribution Channel

  • 12.1. Online
  • 12.2. Offline

13. Heart Valve Devices Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Heart Valve Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Heart Valve Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Edwards Lifesciences Corporation
  • 17.2. Medtronic plc
  • 17.3. Abbott Laboratories
  • 17.4. Boston Scientific Corporation
  • 17.5. Corcym S.r.l.
  • 17.6. Artivion, Inc
  • 17.7. Peijia Medical Limited
  • 17.8. Meril Life Sciences Pvt. Ltd.
  • 17.9. Venus Medtech (Hangzhou) Inc.
  • 17.10. Lepu (Beijing) Medical Devices Co., Ltd.
  • 17.11. Biosensors International Group, Ltd.
  • 17.12. MicroPort Scientific Corporation
  • 17.13. JenaValve Technology, Inc.
  • 17.14. 4C Medical Technologies, Inc.
  • 17.15. Anteris Technologies Global Corp.
  • 17.16. Braile Biomedica
  • 17.17. Colibri Heart Valve LLC
  • 17.18. Foldax, Inc.
  • 17.19. HighLife Medical
  • 17.20. Sahajanand Medical Technologies Limited
  • 17.21. TTK Healthcare Limited
  • 17.22. W. L. Gore & Associates, Inc.
  • 17.23. Xeltis B.V.

LIST OF FIGURES

  • FIGURE 1. GLOBAL HEART VALVE DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL HEART VALVE DEVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL HEART VALVE DEVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL HEART VALVE DEVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL HEART VALVE DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL HEART VALVE DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL AORTIC VALVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL AORTIC VALVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL AORTIC VALVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MITRAL VALVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MITRAL VALVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MITRAL VALVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PULMONARY VALVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PULMONARY VALVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL TRICUSPID VALVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL TRICUSPID VALVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL TRICUSPID VALVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MECHANICAL HEART VALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MECHANICAL HEART VALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MECHANICAL HEART VALVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BILEAFLET MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BILEAFLET MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BILEAFLET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL TILTING DISC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL TILTING DISC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL TILTING DISC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CAGED BALL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CAGED BALL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CAGED BALL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BIOLOGICAL HEART VALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOLOGICAL HEART VALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BIOLOGICAL HEART VALVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL XENOGRAFT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL XENOGRAFT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL XENOGRAFT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HOMOGRAFT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HOMOGRAFT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HOMOGRAFT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL TRANSCATHETER VALVE INTERVENTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL TRANSCATHETER VALVE INTERVENTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL TRANSCATHETER VALVE INTERVENTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL OPEN-HEART SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL OPEN-HEART SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL OPEN-HEART SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SPECIALTY CARDIOLOGY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SPECIALTY CARDIOLOGY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SPECIALTY CARDIOLOGY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL RESEARCH & ACADEMIC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL RESEARCH & ACADEMIC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL RESEARCH & ACADEMIC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 142. GCC HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 143. GCC HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 144. GCC HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. GCC HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 146. GCC HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 147. GCC HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. GCC HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GCC HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. GCC HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 169. G7 HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 170. G7 HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 171. G7 HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. G7 HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 173. G7 HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 174. G7 HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. G7 HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. G7 HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. G7 HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 178. NATO HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 179. NATO HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 180. NATO HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. NATO HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 182. NATO HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 183. NATO HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. NATO HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 185. NATO HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. NATO HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 197. CANADA HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 198. CANADA HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 199. CANADA HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. CANADA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 201. CANADA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 202. CANADA HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. CANADA HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 204. CANADA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. CANADA HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 206. MEXICO HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 207. MEXICO HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 208. MEXICO HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. MEXICO HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 210. MEXICO HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 211. MEXICO HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. MEXICO HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 213. MEXICO HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. MEXICO HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 215. BRAZIL HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 216. BRAZIL HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 217. BRAZIL HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. BRAZIL HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 219. BRAZIL HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 220. BRAZIL HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. BRAZIL HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 222. BRAZIL HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. BRAZIL HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED KINGDOM HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED KINGDOM HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED KINGDOM HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED KINGDOM HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED KINGDOM HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED KINGDOM HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED KINGDOM HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED KINGDOM HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED KINGDOM HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 233. GERMANY HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 234. GERMANY HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 235. GERMANY HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. GERMANY HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 237. GERMANY HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 238. GERMANY HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. GERMANY HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 240. GERMANY HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 241. GERMANY HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 242. FRANCE HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 243. FRANCE HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 244. FRANCE HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. FRANCE HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 246. FRANCE HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 247. FRANCE HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. FRANCE HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 249. FRANCE HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 250. FRANCE HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 251. RUSSIA HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 252. RUSSIA HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 253. RUSSIA HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. RUSSIA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 255. RUSSIA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 256. RUSSIA HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. RUSSIA HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 258. RUSSIA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 259. RUSSIA HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 260. ITALY HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 261. ITALY HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 262. ITALY HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. ITALY HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 264. ITALY HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 265. ITALY HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. ITALY HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 267. ITALY HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 268. ITALY HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 269. SPAIN HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 270. SPAIN HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 271. SPAIN HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. SPAIN HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 273. SPAIN HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 274. SPAIN HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. SPAIN HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 276. SPAIN HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 277. SPAIN HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. CHINA HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 285. CHINA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 286. CHINA HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 287. INDIA HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 288. INDIA HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 289. INDIA HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. INDIA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 291. INDIA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 292. INDIA HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 293. INDIA HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 294. INDIA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 295. INDIA HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 296. JAPAN HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 297. JAPAN HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 298. JAPAN HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. JAPAN HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 300. JAPAN HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 301. JAPAN HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 302. JAPAN HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 303. JAPAN HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 304. JAPAN HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 305. AUSTRALIA HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 306. AUSTRALIA HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 307. AUSTRALIA HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 308. AUSTRALIA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 309. AUSTRALIA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 310. AUSTRALIA HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 311. AUSTRALIA HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 312. AUSTRALIA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 313. AUSTRALIA HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 314. SOUTH KOREA HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 315. SOUTH KOREA HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 316. SOUTH KOREA HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 317. SOUTH KOREA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 318. SOUTH KOREA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 319. SOUTH KOREA HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 320. SOUTH KOREA HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 321. SOUTH KOREA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 322. SOUTH KOREA HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)